Pepts ReMuscle: Optimized solution for muscle health and endurance with IPH AGAA peptide.
Pepts ReMuscle is a highly effective product that contains the IPH AGAA peptide. This natural short-chain peptide actively promotes rapid and healthy muscle tissue regeneration, reduces body fat and improves heart health, making it especially important for athletes and active people.
The scientific basis for the benefits of IPH AGAA peptide:
Accelerated Muscle Recovery: Clinical studies have shown that IPH AGAA significantly accelerates the recovery process of muscle fibers after physical activity, allowing athletes to return to training faster.
Reduce Body Fat: IPH AGAA Peptide influences metabolic processes to help reduce fat mass and improve overall body composition.
Supports Heart Health: IPH AGAA peptide improves the functional health of the heart muscle and helps prevent cardiovascular disease.
Clinical data of IPH AGAA peptide:
Increases the production of vimentin in stem cells by 1.8 times, which improves the cellular structure and function of muscle tissue.
Increased Pax7 protein functionality by 20%, which promotes myocyte growth and repair.
Activation of MYF5 by 2.9 times, accelerating the formation of new muscle cells.
Regulation of p53 protein levels, which controls cell growth and apoptosis, which is important for maintaining healthy muscle tissue.
An increase in the expression of the Ki67 marker by 20%, which indicates active cell division and regeneration.
Pepts ReMuscle offers a complete solution to improve muscle performance and overall fitness. Thanks to the powerful action of IPH AGAA peptide and BCAA support, it promotes effective recovery, maintains muscle tone and improves overall health. The product is designed for those who seek to maximize training results and improve their quality of life by improving muscle health and functionality.
PEPTS product line is based on a platform of three key amino acids – leucine, valine and isoleucine, with IPH peptide complexes selected for each product based on its targeted action. Branched chain amino acids are homogenized by reverse hydrolysis and treated with a fine spray of peptide complexes, which guarantees even distribution and a homogeneous product structure.
Short peptides on an amino acid platform regulate critical physiological processes. Studies have shown that the combined action of short peptides and amino acids stimulates the growth of cells in the cerebral cortex, heart, liver, spleen, blood vessels and muscle tissue, especially in organotypic tissue cultures.
Experiments have confirmed that the presence of terminal amino acids in peptides enhances their stimulating effect on tissue growth. This was particularly noticeable in tissues of the cerebral cortex, liver and spleen, where growth areas were significantly increased compared to control groups. It is important to note that exposure to terminal amino acids with short peptides can significantly enhance the growth of organotypic tissue cultures. Peptides in combination with amino acids have proven to be particularly effective in stimulating the growth of vascular tissues.
Studies demonstrate that the effect of amino acids with short peptides on organotypic tissue cultures increases the stimulation of growth of the cerebral cortex, spleen, liver and heart by 20-22%, growth of the liver and spleen by 16-19%. When adding terminal amino acids to peptides, the effectiveness increases to 31-41%. and for vascular tissues, growth increased by 61-74%.
It is especially important that the stimulating effect of the combination of peptides and amino acids is due to their ability to penetrate the cytoplasm and nucleus of cells, bind to DNA, and also regulate specific genes at the transcriptional and translational levels, which contributes to the regulation of cellular metabolism.
Product name: peptide complex IPH AGAA
Specification product: HPLC/MS <1.0 %
Peripheral amino acid residues: Alanine, Glutamic Acid, Aspartic Acid, Arginine
Total content protein: Kjeldahl ~ 59 %
Total content free amino acids: LC-MS/MS ~ 40%
